NAD+ drips and injections: will they give you more energy?

NAD+ is a molecule every cell uses to turn food into energy; it isn't a peptide. NAD+ drips and injections are popular for energy and healthy aging, but human studies are small and mostly measure blood levels, not how people feel. It isn't part of the October 2026 HHS peptide policy. For more energy as you age, the steps with the strongest evidence are ones a physician can help with.

Reviewed by Darshan Patel, MD, Obesity medicine physician, on 2026-11-12. Next review 2026-12-12.

Book my consultation Video consultations with an Aayu Well physician. Most major insurance accepted, plus convenient cash pay options.

Why people are curious about NAD+

NAD+ has become a wellness favorite. IV lounges and clinics sell drips and shots for more energy, a clearer head and "anti-aging" benefits. The idea makes sense on paper: NAD+ helps every cell make energy, and levels fall with age in some tissues.

Wanting more energy as you get older is a great goal. The real question is whether NAD+ drips are the best way to get there.

What the research shows so far

Evidence grade C: limited. There are human studies, but they're small and mostly measure blood levels. How we grade evidence.

  • NAD+ drips and shots: a small pilot study of a six-hour IV drip in healthy men tracked how NAD+ changed in blood and urine. It didn't test whether people felt better, and controlled trials for energy or aging haven't been published.
  • NR and NMN pills: randomized trials show these building blocks raise NAD+ in blood and are generally well tolerated over weeks to months. Effects on blood pressure, muscle and blood sugar control have been small or mixed.
  • In mice: raising NAD+ improved several markers of aging, which drives much of the interest.
  • Still open: whether drips or shots improve energy, thinking or lifespan in people, and long-term safety.

Your goal, with stronger evidence behind it

The steps with the strongest evidence for energy and healthy aging aren't flashy, but they've been tested in people, and a physician can help with each one.

  • Sleep well. Short sleep and untreated sleep apnea both leave people sleepy and foggy during the day, and both can be treated.
  • Build strength. Strength work twice a week keeps muscle as you age, and muscle keeps you moving.
  • Reach a healthier weight. For people living with obesity, GLP-1 medicines such as semaglutide and tirzepatide have been tested in large trials with thousands of people. Under specialist care, they quiet hunger and improve health numbers.
  • Keep blood sugar and blood pressure in range. Both shape how you feel day to day and how well you age.

Aayu Elevate™ puts this together: video visits with an obesity medicine physician, a registered dietitian, and medicine when it's right for you. If mood or sleep is part of your story, Elevate Plus™ adds care for them. Most major insurance accepted, plus convenient cash pay options. Book my consultation

Is NAD+ legal now?

It depends on who makes it. NAD+ isn't a peptide, so it isn't part of the October 2026 HHS peptide policy. For regular pharmacies, FDA lists NAD+ among ingredients it is still evaluating, and until it decides, it doesn't plan to act against pharmacies that compound it under set conditions. That isn't approval. In January 2026, FDA told one outsourcing facility that NAD+ isn't eligible under the rules for that kind of facility. State rules on IV therapy also apply. See which peptides can be compounded.

Good to know before you try it

  • Compounded NAD+ is not FDA-approved, and no one has studied drips or shots over months or years.
  • The one published pilot study gave the drip slowly, over six hours, to eight men and saw no side effects. It was far too small to show how often problems happen.
  • Any IV or injection should come from a licensed pharmacy and be given by a licensed clinician, to keep the risk of infection low.
  • If you have cancer, ask your oncologist first, and skip it if you're pregnant or breastfeeding.

Where Aayu Well stands

We don't prescribe NAD+ right now. We're following the research and the pharmacy rules closely, and we review this page every month.

What we can help with today is usually what sits behind the question: energy, weight, metabolic health, sleep and mood. Bring your questions to your first visit. Your physician will give you a straight answer and a plan built around you. For more on the basics, see our healthy aging guide.

Questions people ask

Can I talk to an Aayu Well physician about peptides?

Yes, and NAD+ too. Bring your questions to your visit. We don't prescribe NAD+ right now, but your physician will go over the evidence with you, review everything you take, and build a plan for the goal behind the question, whether that's energy, weight, sleep or mood.

Is NAD+ a peptide?

No. NAD+ is a coenzyme your body makes from vitamin B3 and related nutrients. Clinics often sell it next to peptides, which is why it's in our peptide guides.

Is NAD+ legal?

It isn't part of the October 2026 HHS peptide policy. For regular pharmacies, FDA lists NAD+ as an ingredient it is still evaluating and doesn't plan to act against them while it decides, if they meet its conditions. FDA has said outsourcing facilities can't use it. Compounded NAD+ is not FDA-approved.

Do NAD+ drips work?

There isn't good human evidence yet that NAD+ drips or injections improve energy, thinking or aging. Studies so far are small and measure blood levels.

Can I take it with a GLP-1 like Wegovy or Zepbound?

No studies have looked at the two together, so it's worth a conversation first. Tell the physician who prescribes your GLP-1 about any infusion or injection you use.

Bring your questions about NAD+ to a physician

In one video visit, an obesity medicine physician looks at the whole picture: your energy, weight, sleep, mood and metabolic health. You leave with a plan built on what works, and straight answers about anything you've read online.

Book my consultation

Sources

  1. FDA: Bulk drug substances nominated for use in compounding under section 503A, categories 1 to 3 (updated May 14, 2026)
  2. FDA: Bulk drug substances used in compounding under section 503A, including the interim policy for category 1
  3. FDA warning letter to GenoGenix LLC, WL 718739 (January 20, 2026)
  4. HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (October 2026)
  5. Grant R, Berg J, Mestayer R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019;11:257. doi:10.3389/fnagi.2019.00257
  6. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7
  7. Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026;116:103057. doi:10.1016/j.arr.2026.103057
  8. NHLBI: How sleep deprivation and deficiency affect your health
  9. NHLBI: What is sleep apnea?
  10. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
  11. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038